One cheek swab, four areas of insight: predisposition to common disease, inherited conditions and carrier status, pharmacogenomics, and traits, wellness and ancestry.
DNAlyse OÜ acts solely as a facilitator of genetic analysis services provided by certified and compliant third-party laboratories. We specialize in serving medical professionals, researchers, and institutional clients in need of reliable, data-driven genetic insights.
We do not access, store, or process personal or genetic data. Our role is limited to enabling secure and efficient access to genetic testing services for informational and research-support purposes only.
Our services are not intended for clinical diagnosis or medical decision-making. Any health-related conclusions drawn from the data should always be interpreted by qualified healthcare professionals within a clinical context.
From swab to report — three stages, each with a defined quality threshold.
Collection is by cheek swab. The swab is rubbed against the inside of the cheek, then sealed into an integrated drying chamber that draws the moisture out and holds the DNA stable at ambient temperature. There is no liquid buffer and no cold chain — kits are returned by ordinary post.
At the laboratory, DNA is extracted and quantified before anything else happens. Samples below the quality threshold are re-extracted or rejected rather than carried forward — no amount of interpretation recovers a poor extraction.
Extracted DNA is amplified and hybridised to a high-density genotyping array. Each probe position interrogates one location in the genome; fluorescence intensity at that probe determines which allele is present. The array covers over 700,000 sites, extended with additional clinically informative positions.
Array genotyping reads pre-selected positions rather than sequencing the genome end to end. That is a deliberate choice, not a limitation we work around: reproducibility across a fixed probe set is very high and cost per sample is a fraction of sequencing — which matters when the positions with real published evidence behind them number in the hundreds of thousands, not the billions.
Genotype calls are extended by statistical imputation against reference panels, then matched against curated variant sets drawn from genome-wide association studies and whole-genome sequencing literature. Effect sizes are population-referenced, so a result reads as risk relative to a comparison group rather than as an absolute number with no denominator.
Interpretation is version-controlled. When the evidence behind a variant shifts — a replication fails, an effect size is revised, a new association reaches significance — affected reports are regenerated and reissued to existing clients at no further cost. No new sample is required.
DNAlyse OÜ does not operate a laboratory. Genotyping is performed by a contract laboratory in the European Union, accredited to ISO 17025 for the testing methods used in this service.
That accreditation belongs to the analysing laboratory, not to DNAlyse OÜ. We hold no laboratory accreditation and make no claim to one.
The analysing laboratory is identified to patients by name at the point of informed consent, together with the legal basis for processing, the retention period, and the jurisdiction in which samples are handled. Professional partners and distributors may request provider information directly by contacting info@dnalyse.com.
Quantified risk across multifactorial conditions where the genetic contribution is well characterised — type 2 diabetes, coronary artery disease, osteoporosis, inflammatory bowel disease, age-related macular degeneration among others. Reported as risk relative to a reference population, with the contributing variants listed so the result can be interrogated rather than merely read.
See the full list
Monogenic conditions across recessive and dominant inheritance patterns. Carrier findings are reported as carrier status without implication of phenotype — relevant to reproductive counselling and to family-history work, and frequently the part of the panel clinicians find most immediately actionable.
See the full list
Metabolism and response profiles across commonly prescribed classes: anticoagulants, statins, proton-pump inhibitors, analgesics including codeine and tramadol, SSRIs, and local and general anaesthetics.
Pharmacogenomic results inform prescribing decisions; they do not replace them. No patient should start, stop, or alter the dose of any medication on the basis of this report without consulting their prescribing physician.
See the full list
Nutrient and micronutrient metabolism, caffeine and alcohol processing, physical and sensory traits, and biogeographical ancestry with maternal and paternal lineage assignment.
See the full list
Designed specifically for researchers, healthcare professionals, and institutional clients. Every reported item traces back to published evidence — no novelty reports or fluff.
Risk is reported relative to a reference population, with the contributing variants listed. That makes a result auditable rather than merely readable, and comparable across a cohort.
We prioritize the markers with clinical weight — diabetes, cardiovascular risk, drug metabolism — rather than listing rare or recreational traits to inflate a headline number.
Over 400 reports grouped into four areas that match how the findings are actually used in practice, rather than split into categories to make the panel look larger.
Fast and reliable shipping of test kits, free of charge. Dry-swab kits travel at ambient temperature in both directions — no cold chain to arrange.
When the evidence behind a variant changes, affected reports are regenerated and reissued at no further cost. No new sample is required.
Our pricing structure is tailored for research projects, medical practices, and bulk testing — making high-quality analysis accessible and scalable.
This test was a valuable addition to my research project — it delivered actionable insights with clear, quantifiable results. I will definitely use it again in future studies.— Dr. Daniel Palkovics, Semmelweis University, Hungary
One sample, four areas of insight, over 400 reports.